Tarak D. Mody

Tarak D. Mody, Ph.D., is an accomplished professional with extensive experience in business development and strategic management within the biopharmaceutical industry. Currently serving as a Strategic Business Development and Investment Advisor at the Multiple Myeloma Research Foundation and a Therapeutics Adviser for the UCLA Technology Development Group, Mody also holds a position as an Independent Board Member at INNOVOTEX INC. Previously, as Chief Business Officer at the Parker Institute for Cancer Immunotherapy, Mody led corporate business development efforts. Experience includes significant roles at Amgen, Five Prime Therapeutics, and Pharmacyclics, where Mody was integral to establishing key strategic alliances and advancing drug development initiatives. Mody holds a Ph.D. in Bioinorganic Chemistry/Synthetic Chemistry from The University of Texas at Austin and dual Bachelor of Science degrees in Chemistry from Villanova University.